Inventor
Neil OTTO
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07KPeptides18%
C12YEnzymes18%
PatentTitleYear
12,097,220Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods202412,037,611Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods202411,760,983Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods202311,278,570Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods202211,162,084Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to B MOGEN BIOTECHNOLOGIES INC (3)· patent assignee history
2021–2024Based in US· patent location history
2024Patents assigned to R&D SYSTEMS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| B MOGEN BIOTECHNOLOGIES INC | 3 | 2021–2023 |
| R&D SYSTEMS INC | 2 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2024 |